Company Valuation: Vertex Pharmaceuticals Incorporated

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Capitalization 1 61,457 55,834 74,127 104,849 103,707 120,399 - -
Change - -9.15% 32.76% 41.44% -1.09% 16.1% - -
Enterprise Value (EV) 1 54,798 48,309 63,349 93,630 97,591 110,769 105,016 98,712
Change - -11.84% 31.13% 47.8% 4.23% 13.5% -5.19% -6%
P/E ratio 23x 24.4x 22.5x 29.3x -194x 31.2x 26.6x 22.9x
PBR 7.07x 5.53x 5.33x 5.96x 6.4x 6.09x 5.42x 4.61x
PEG - -2x 0.5x 3.51x 2x -0x 1.6x 1.4x
Capitalization / Revenue 9.9x 7.37x 8.3x 10.6x 9.41x 10.1x 9.16x 8.4x
EV / Revenue 8.83x 6.38x 7.09x 9.49x 8.86x 9.28x 7.99x 6.89x
EV / EBITDA 15.2x 10.8x 12.8x 20.6x 108x 19.5x 15.8x 13.7x
EV / EBIT 15.7x 11.1x 13.2x 21.4x 140x 20.5x 16.6x 14.3x
EV / FCF 18.3x 20.1x 16.1x 28.1x -123x 26.2x 21.8x 17.5x
FCF Yield 5.46% 4.99% 6.2% 3.56% -0.81% 3.82% 4.58% 5.72%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 10.29 9.01 12.82 13.89 -2.08 15.04 17.61 20.51
Distribution rate - - - - - - - -
Net sales 1 6,206 7,574 8,931 9,869 11,020 11,936 13,146 14,332
EBITDA 1 3,601 4,470 4,941 4,556 902.8 5,671 6,645 7,198
EBIT 1 3,491 4,344 4,793 4,375 695.6 5,398 6,326 6,905
Net income 1 2,712 2,342 3,322 3,620 -535.6 3,892 4,447 5,251
Net Debt 1 -6,659 -7,525 -10,778 -11,218 -6,116 -9,630 -15,383 -21,687
Reference price 2 236.34 219.60 288.78 406.89 402.70 468.85 468.85 468.85
Nbr of stocks (in thousands) 260,038 254,252 256,691 257,683 257,529 256,797 - -
Announcement Date 01/02/21 26/01/22 07/02/23 05/02/24 10/02/25 - - -
1USD in Million2USD
Estimates

P/E ratio, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
31.18x9.28x19.53x-.--% 120B
37.3x12.31x28.09x0.75% 712B
15.04x4.2x11.56x3.34% 378B
27.26x6.59x13.78x3.42% 340B
16.85x6.08x12.14x3% 305B
14.15x3.48x8.6x3.84% 259B
17.15x4.63x11.21x3.26% 237B
22.3x4.15x12.2x2.28% 219B
10.68x3.46x7.48x3.86% 209B
22.58x5.78x11.22x3.25% 159B
Average 21.45x 6.00x 13.58x 2.7% 293.74B
Weighted average by Cap. 23.43x 6.85x 15.66x 2.54%
See all sector valuations

Year-on-year evolution of the PER

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Equities
  3. VRTX Stock
  4. Valuation Vertex Pharmaceuticals Incorporated